Liver Failure Therapeutics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Failure Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ornithine Phenylacetate
1.2.3 MTL-CEBPA
1.2.4 F-573
1.2.5 BL-1220
1.2.6 PP-100
1.2.7 Others
1.3 Market by Application
1.3.1 Global Liver Failure Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Liver Failure Therapeutics Market Perspective (2017-2028)
2.2 Liver Failure Therapeutics Growth Trends by Region
2.2.1 Liver Failure Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Liver Failure Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Liver Failure Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Liver Failure Therapeutics Market Dynamics
2.3.1 Liver Failure Therapeutics Industry Trends
2.3.2 Liver Failure Therapeutics Market Drivers
2.3.3 Liver Failure Therapeutics Market Challenges
2.3.4 Liver Failure Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Failure Therapeutics Players by Revenue
3.1.1 Global Top Liver Failure Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Liver Failure Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liver Failure Therapeutics Revenue
3.4 Global Liver Failure Therapeutics Market Concentration Ratio
3.4.1 Global Liver Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Failure Therapeutics Revenue in 2021
3.5 Liver Failure Therapeutics Key Players Head office and Area Served
3.6 Key Players Liver Failure Therapeutics Product Solution and Service
3.7 Date of Enter into Liver Failure Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Failure Therapeutics Breakdown Data by Type
4.1 Global Liver Failure Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Liver Failure Therapeutics Forecasted Market Size by Type (2023-2028)
5 Liver Failure Therapeutics Breakdown Data by Application
5.1 Global Liver Failure Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Liver Failure Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Liver Failure Therapeutics Market Size (2017-2028)
6.2 North America Liver Failure Therapeutics Market Size by Type
6.2.1 North America Liver Failure Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Liver Failure Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Liver Failure Therapeutics Market Share by Type (2017-2028)
6.3 North America Liver Failure Therapeutics Market Size by Application
6.3.1 North America Liver Failure Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Liver Failure Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Liver Failure Therapeutics Market Share by Application (2017-2028)
6.4 North America Liver Failure Therapeutics Market Size by Country
6.4.1 North America Liver Failure Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Liver Failure Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Liver Failure Therapeutics Market Size (2017-2028)
7.2 Europe Liver Failure Therapeutics Market Size by Type
7.2.1 Europe Liver Failure Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Liver Failure Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Liver Failure Therapeutics Market Share by Type (2017-2028)
7.3 Europe Liver Failure Therapeutics Market Size by Application
7.3.1 Europe Liver Failure Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Liver Failure Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Liver Failure Therapeutics Market Share by Application (2017-2028)
7.4 Europe Liver Failure Therapeutics Market Size by Country
7.4.1 Europe Liver Failure Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Liver Failure Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liver Failure Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Liver Failure Therapeutics Market Size by Type
8.2.1 Asia-Pacific Liver Failure Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Liver Failure Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Liver Failure Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Liver Failure Therapeutics Market Size by Application
8.3.1 Asia-Pacific Liver Failure Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Liver Failure Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Liver Failure Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Liver Failure Therapeutics Market Size by Region
8.4.1 Asia-Pacific Liver Failure Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Liver Failure Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Liver Failure Therapeutics Market Size (2017-2028)
9.2 Latin America Liver Failure Therapeutics Market Size by Type
9.2.1 Latin America Liver Failure Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Liver Failure Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Liver Failure Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Liver Failure Therapeutics Market Size by Application
9.3.1 Latin America Liver Failure Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Liver Failure Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Liver Failure Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Liver Failure Therapeutics Market Size by Country
9.4.1 Latin America Liver Failure Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Liver Failure Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Failure Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Liver Failure Therapeutics Market Size by Type
10.2.1 Middle East & Africa Liver Failure Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Liver Failure Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Liver Failure Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Liver Failure Therapeutics Market Size by Application
10.3.1 Middle East & Africa Liver Failure Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Liver Failure Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Liver Failure Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Liver Failure Therapeutics Market Size by Country
10.4.1 Middle East & Africa Liver Failure Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Liver Failure Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alfact Innovation
11.1.1 Alfact Innovation Company Details
11.1.2 Alfact Innovation Business Overview
11.1.3 Alfact Innovation Liver Failure Therapeutics Introduction
11.1.4 Alfact Innovation Revenue in Liver Failure Therapeutics Business (2017-2022)
11.1.5 Alfact Innovation Recent Developments
11.2 BioLineRx Ltd
11.2.1 BioLineRx Ltd Company Details
11.2.2 BioLineRx Ltd Business Overview
11.2.3 BioLineRx Ltd Liver Failure Therapeutics Introduction
11.2.4 BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2017-2022)
11.2.5 BioLineRx Ltd Recent Developments
11.3 Cell2B Advanced Therapeutics SA
11.3.1 Cell2B Advanced Therapeutics SA Company Details
11.3.2 Cell2B Advanced Therapeutics SA Business Overview
11.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Introduction
11.3.4 Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2017-2022)
11.3.5 Cell2B Advanced Therapeutics SA Recent Developments
11.4 Conatus Pharmaceuticals Inc
11.4.1 Conatus Pharmaceuticals Inc Company Details
11.4.2 Conatus Pharmaceuticals Inc Business Overview
11.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Introduction
11.4.4 Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2017-2022)
11.4.5 Conatus Pharmaceuticals Inc Recent Developments
11.5 Immune Pharmaceuticals Inc
11.5.1 Immune Pharmaceuticals Inc Company Details
11.5.2 Immune Pharmaceuticals Inc Business Overview
11.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Introduction
11.5.4 Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2017-2022)
11.5.5 Immune Pharmaceuticals Inc Recent Developments
11.6 Mina Therapeutics Ltd
11.6.1 Mina Therapeutics Ltd Company Details
11.6.2 Mina Therapeutics Ltd Business Overview
11.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Introduction
11.6.4 Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2017-2022)
11.6.5 Mina Therapeutics Ltd Recent Developments
11.7 Mylan NV
11.7.1 Mylan NV Company Details
11.7.2 Mylan NV Business Overview
11.7.3 Mylan NV Liver Failure Therapeutics Introduction
11.7.4 Mylan NV Revenue in Liver Failure Therapeutics Business (2017-2022)
11.7.5 Mylan NV Recent Developments
11.8 Ocera Therapeutics Inc
11.8.1 Ocera Therapeutics Inc Company Details
11.8.2 Ocera Therapeutics Inc Business Overview
11.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Introduction
11.8.4 Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2017-2022)
11.8.5 Ocera Therapeutics Inc Recent Developments
11.9 PledPharma AB
11.9.1 PledPharma AB Company Details
11.9.2 PledPharma AB Business Overview
11.9.3 PledPharma AB Liver Failure Therapeutics Introduction
11.9.4 PledPharma AB Revenue in Liver Failure Therapeutics Business (2017-2022)
11.9.5 PledPharma AB Recent Developments
11.10 Promethera Biosciences SA
11.10.1 Promethera Biosciences SA Company Details
11.10.2 Promethera Biosciences SA Business Overview
11.10.3 Promethera Biosciences SA Liver Failure Therapeutics Introduction
11.10.4 Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2017-2022)
11.10.5 Promethera Biosciences SA Recent Developments
11.11 Silence Therapeutics Plc
11.11.1 Silence Therapeutics Plc Company Details
11.11.2 Silence Therapeutics Plc Business Overview
11.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Introduction
11.11.4 Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2017-2022)
11.11.5 Silence Therapeutics Plc Recent Developments
11.12 Unicyte AG
11.12.1 Unicyte AG Company Details
11.12.2 Unicyte AG Business Overview
11.12.3 Unicyte AG Liver Failure Therapeutics Introduction
11.12.4 Unicyte AG Revenue in Liver Failure Therapeutics Business (2017-2022)
11.12.5 Unicyte AG Recent Developments
11.13 Ventria Bioscience
11.13.1 Ventria Bioscience Company Details
11.13.2 Ventria Bioscience Business Overview
11.13.3 Ventria Bioscience Liver Failure Therapeutics Introduction
11.13.4 Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2017-2022)
11.13.5 Ventria Bioscience Recent Developments
11.14 Vital Therapies Inc
11.14.1 Vital Therapies Inc Company Details
11.14.2 Vital Therapies Inc Business Overview
11.14.3 Vital Therapies Inc Liver Failure Therapeutics Introduction
11.14.4 Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2017-2022)
11.14.5 Vital Therapies Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Liver Failure Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Ornithine Phenylacetate
Table 3. Key Players of MTL-CEBPA
Table 4. Key Players of F-573
Table 5. Key Players of BL-1220
Table 6. Key Players of PP-100
Table 7. Key Players of Others
Table 8. Global Liver Failure Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Liver Failure Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Liver Failure Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Liver Failure Therapeutics Market Share by Region (2017-2022)
Table 12. Global Liver Failure Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Liver Failure Therapeutics Market Share by Region (2023-2028)
Table 14. Liver Failure Therapeutics Market Trends
Table 15. Liver Failure Therapeutics Market Drivers
Table 16. Liver Failure Therapeutics Market Challenges
Table 17. Liver Failure Therapeutics Market Restraints
Table 18. Global Liver Failure Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Liver Failure Therapeutics Revenue Share by Players (2017-2022)
Table 20. Global Top Liver Failure Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Failure Therapeutics as of 2021)
Table 21. Ranking of Global Top Liver Failure Therapeutics Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Liver Failure Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Liver Failure Therapeutics Product Solution and Service
Table 25. Date of Enter into Liver Failure Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Liver Failure Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Liver Failure Therapeutics Revenue Market Share by Type (2017-2022)
Table 29. Global Liver Failure Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Liver Failure Therapeutics Revenue Market Share by Type (2023-2028)
Table 31. Global Liver Failure Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Liver Failure Therapeutics Revenue Share by Application (2017-2022)
Table 33. Global Liver Failure Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Liver Failure Therapeutics Revenue Share by Application (2023-2028)
Table 35. North America Liver Failure Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Liver Failure Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Liver Failure Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Liver Failure Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Liver Failure Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Liver Failure Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Liver Failure Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Liver Failure Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Liver Failure Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Liver Failure Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Liver Failure Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Liver Failure Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Liver Failure Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Liver Failure Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Liver Failure Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Liver Failure Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Liver Failure Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Liver Failure Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Liver Failure Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Liver Failure Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Liver Failure Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Liver Failure Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Liver Failure Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Liver Failure Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Liver Failure Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Liver Failure Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Liver Failure Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Liver Failure Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Liver Failure Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Liver Failure Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 65. Alfact Innovation Company Details
Table 66. Alfact Innovation Business Overview
Table 67. Alfact Innovation Liver Failure Therapeutics Product
Table 68. Alfact Innovation Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Alfact Innovation Recent Developments
Table 70. BioLineRx Ltd Company Details
Table 71. BioLineRx Ltd Business Overview
Table 72. BioLineRx Ltd Liver Failure Therapeutics Product
Table 73. BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 74. BioLineRx Ltd Recent Developments
Table 75. Cell2B Advanced Therapeutics SA Company Details
Table 76. Cell2B Advanced Therapeutics SA Business Overview
Table 77. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product
Table 78. Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Cell2B Advanced Therapeutics SA Recent Developments
Table 80. Conatus Pharmaceuticals Inc Company Details
Table 81. Conatus Pharmaceuticals Inc Business Overview
Table 82. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product
Table 83. Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Conatus Pharmaceuticals Inc Recent Developments
Table 85. Immune Pharmaceuticals Inc Company Details
Table 86. Immune Pharmaceuticals Inc Business Overview
Table 87. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product
Table 88. Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 89. Immune Pharmaceuticals Inc Recent Developments
Table 90. Mina Therapeutics Ltd Company Details
Table 91. Mina Therapeutics Ltd Business Overview
Table 92. Mina Therapeutics Ltd Liver Failure Therapeutics Product
Table 93. Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Mina Therapeutics Ltd Recent Developments
Table 95. Mylan NV Company Details
Table 96. Mylan NV Business Overview
Table 97. Mylan NV Liver Failure Therapeutics Product
Table 98. Mylan NV Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 99. Mylan NV Recent Developments
Table 100. Ocera Therapeutics Inc Company Details
Table 101. Ocera Therapeutics Inc Business Overview
Table 102. Ocera Therapeutics Inc Liver Failure Therapeutics Product
Table 103. Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 104. Ocera Therapeutics Inc Recent Developments
Table 105. PledPharma AB Company Details
Table 106. PledPharma AB Business Overview
Table 107. PledPharma AB Liver Failure Therapeutics Product
Table 108. PledPharma AB Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 109. PledPharma AB Recent Developments
Table 110. Promethera Biosciences SA Company Details
Table 111. Promethera Biosciences SA Business Overview
Table 112. Promethera Biosciences SA Liver Failure Therapeutics Product
Table 113. Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 114. Promethera Biosciences SA Recent Developments
Table 115. Silence Therapeutics Plc Company Details
Table 116. Silence Therapeutics Plc Business Overview
Table 117. Silence Therapeutics Plc Liver Failure Therapeutics Product
Table 118. Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 119. Silence Therapeutics Plc Recent Developments
Table 120. Unicyte AG Company Details
Table 121. Unicyte AG Business Overview
Table 122. Unicyte AG Liver Failure Therapeutics Product
Table 123. Unicyte AG Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 124. Unicyte AG Recent Developments
Table 125. Ventria Bioscience Company Details
Table 126. Ventria Bioscience Business Overview
Table 127. Ventria Bioscience Liver Failure Therapeutics Product
Table 128. Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 129. Ventria Bioscience Recent Developments
Table 130. Vital Therapies Inc Company Details
Table 131. Vital Therapies Inc Business Overview
Table 132. Vital Therapies Inc Liver Failure Therapeutics Product
Table 133. Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 134. Vital Therapies Inc Recent Developments
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Failure Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Ornithine Phenylacetate Features
Figure 3. MTL-CEBPA Features
Figure 4. F-573 Features
Figure 5. BL-1220 Features
Figure 6. PP-100 Features
Figure 7. Others Features
Figure 8. Global Liver Failure Therapeutics Market Share by Application: 2021 VS 2028
Figure 9. Clinic Case Studies
Figure 10. Hospital Case Studies
Figure 11. Others Case Studies
Figure 12. Liver Failure Therapeutics Report Years Considered
Figure 13. Global Liver Failure Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Liver Failure Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Liver Failure Therapeutics Market Share by Region: 2021 VS 2028
Figure 16. Global Liver Failure Therapeutics Market Share by Players in 2021
Figure 17. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Failure Therapeutics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Liver Failure Therapeutics Revenue in 2021
Figure 19. North America Liver Failure Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Liver Failure Therapeutics Market Size Market Share by Type (2017-2028)
Figure 21. North America Liver Failure Therapeutics Market Size Market Share by Application (2017-2028)
Figure 22. North America Liver Failure Therapeutics Market Size Share by Country (2017-2028)
Figure 23. United States Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Liver Failure Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Liver Failure Therapeutics Market Size Market Share by Type (2017-2028)
Figure 27. Europe Liver Failure Therapeutics Market Size Market Share by Application (2017-2028)
Figure 28. Europe Liver Failure Therapeutics Market Size Share by Country (2017-2028)
Figure 29. Germany Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Liver Failure Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Liver Failure Therapeutics Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Liver Failure Therapeutics Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Liver Failure Therapeutics Market Size Share by Region (2017-2028)
Figure 39. China Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Liver Failure Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Liver Failure Therapeutics Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Liver Failure Therapeutics Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Liver Failure Therapeutics Market Size Share by Country (2017-2028)
Figure 49. Mexico Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Liver Failure Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Liver Failure Therapeutics Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Liver Failure Therapeutics Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Liver Failure Therapeutics Market Size Share by Country (2017-2028)
Figure 55. Turkey Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Liver Failure Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Alfact Innovation Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 59. BioLineRx Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 60. Cell2B Advanced Therapeutics SA Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 61. Conatus Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 62. Immune Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 63. Mina Therapeutics Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 64. Mylan NV Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 65. Ocera Therapeutics Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 66. PledPharma AB Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 67. Promethera Biosciences SA Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 68. Silence Therapeutics Plc Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 69. Unicyte AG Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 70. Ventria Bioscience Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 71. Vital Therapies Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Industry Market Size
